Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

Eli Lilly is selling Zepbound in vials at a reduced cost. They have filed lawsuits against medical spas and online vendors selling products falsely claiming to contain tirzepatide, a key ingredient in Zepbound. The lawsuits aim to protect consumers from false claims and risks.

Read More

Did you find this insightful?